{"filings":[{"id":746526,"accession_number":"0000070318-26-000028","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2026-05-29T20:05:19+00:00","items":["5.07"],"status":"ready","headline":"Tenet Healthcare shareholders elect all 12 director nominees, approve say-on-pay, ratify auditor","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All 12 director nominees elected; Saumya Sutaria received 72.3M for, 2.0M against, 76.9K abstain.","Advisory vote on executive compensation approved: 62.6M for (83.5%), 11.8M against, 39.9K abstain.","Ratification of Deloitte & Touche as auditor for 2026 approved: 79.4M for, 470K against, 29.3K abstain."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":98374,"accession_number":"0000070318-26-000023","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2026-04-30T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Tenet Q1 GAAP EPS $8.01, adj EPS $4.82 beats; Ambulatory EBITDA up 6.1%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income available to common shareholders $702M ($8.01 diluted EPS); adjusted diluted EPS $4.82 vs $4.36 YoY.","Consolidated revenue $5,368M (+2.8% YoY); adjusted EBITDA $1,162M (flat) with margin 21.6%.","Ambulatory segment adjusted EBITDA $484M (+6.1% YoY); same-facility revenues up 5.3%.","Hospital segment adjusted EBITDA $678M (-4.1% YoY); same-hospital revenues flat due to payer mix.","FY2026 adj EBITDA outlook reaffirmed $4.485B-$4.785B; repurchased 1.35M shares for $318M."],"consensus_eps_estimate":null,"consensus_eps_actual":8.01,"consensus_revenue_estimate":null,"consensus_revenue_actual":5368000000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":98373,"accession_number":"0000070318-26-000019","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2026-04-10T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Tenet Healthcare CIO Paola Arbour to retire Dec 31, 2026; part-time transition through April 2028","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["EVP and CIO Arbour retires from executive role Dec 31, 2026, stays part-time as non-executive through April 1, 2028 at $820/week.","She remains eligible for 2026 AIP bonus but not 2027; outstanding equity awards continue vesting.","ERA contributions end after 2026; she continues medical benefits and service credit through April 2028.","Agreement includes general release of claims; she will sign supplemental release on last day."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":113795,"accession_number":"0000070318-26-000015","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2026-03-30T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Tenet Healthcare appoints J. Michael Grooms as new Controller, Principal Accounting Officer","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Retirement date of principal accounting officer R. Scott Ramsey changed to April 30, 2026; Ramsey to stay part-time through March 2028.","J. Michael Grooms appointed SVP & Controller effective April 6, 2026, becoming principal accounting officer on May 1, 2026.","Grooms previously served as SVP, Chief Accounting Officer at Lifepoint Health since 2018.","Grooms receives $475k base salary, 60% target bonus, $500k RSU grant, and $250k sign-on bonus.","Grooms also recommended for 2027 equity award of $350k, split 50/50 service/performance RSUs."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":113794,"accession_number":"0000070318-26-000007","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2026-02-11T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Tenet Q4 2025 adjusted EPS $4.70, up 36.6% YoY; FY2026 EBITDA guidance $4.485-$4.785B","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net income $371M ($4.22 diluted EPS); adjusted EPS $4.70 vs $3.44 YoY; revenue $5.527B (+9% YoY).","Consolidated Adj EBITDA $1.183B (+12.9%), margin 21.4%; Ambulatory EBITDA $580M (+9.4%), Hospital EBITDA $603M (+16.4%).","FY2026 outlook: Adj EBITDA $4.485-$4.785B, revenue $21.5-$22.3B; free cash flow $2.94-$3.29B.","Announced $1.9B payment from CommonSpirit over 3 years; Conifer stake redemption; recording $1.65B contract termination revenue in 2026.","Repurchased 8.8M shares for $1.386B in FY2025; completed $2.25B debt refinancing in Nov 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":15.49,"consensus_revenue_estimate":null,"consensus_revenue_actual":21310000000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":113793,"accession_number":"0000070318-26-000003","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2026-02-02T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"Tenet announces $1.9B CommonSpirit deal; 2025 Adj. EBITDA at upper end of guidance","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["CommonSpirit to pay Tenet $1.9B over 3 years; Tenet redeems CommonSpirit's 23.8% Conifer equity for $540M.","Balance sheet: redeemable non-controlling interest and liabilities reduced ~$885M; APIC increased ~$305M.","Preliminary 2025 Adj. EBITDA at upper end of $4.47B-$4.57B range; strong revenue growth and expense management.","Conifer continues to serve CommonSpirit through 2026; Tenet to invest in AI and automation for Conifer.","Full Q4 and FY 2025 results to be reported on February 11, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":130203,"accession_number":"0000070318-25-000050","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2025-11-24T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Stephen H. Rusckowski resigns from Tenet Healthcare board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Stephen H. Rusckowski resigned from the Board effective November 21, 2025.","Board size decreased from 13 to 12 directors.","No reason for resignation or replacement named."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":130202,"accession_number":"0001193125-25-286146","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2025-11-18T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Tenet issues $2.25B in notes to refinance near-term debt maturities","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $1.5B of 5.500% senior secured first lien notes due 2032 and $750M of 6.000% senior notes due 2033.","Proceeds plus cash on hand to redeem $1.5B of 6.250% notes due 2027 and partially redeem $0.75B of 6.125% notes due 2028.","First lien notes secured; senior notes unsecured; both have change-of-control and optional redemption provisions.","Covenants restrict liens, asset sales, and mergers but not additional debt, dividends, or investments."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":130201,"accession_number":"0001193125-25-266885","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2025-11-05T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Tenet enters $1.9B ABL revolving credit facility maturing 2030","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["New $1.9B senior secured revolving credit facility with $200M letter-of-credit sub-facility.","Facility matures Nov 4, 2030, with springing maturity if certain senior notes exceed $2.5B.","Existing $200M LC facility amended to extend maturity from 2027 to Nov 4, 2030.","ABL interest: base rate +0.25%-0.50% or SOFR/EURIBOR +1.25%-1.50% based on average quarterly availability.","JPMorgan Chase is administrative agent; Barclays Bank PLC is LC facility agent."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":130200,"accession_number":"0000070318-25-000048","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2025-11-03T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"Tenet Healthcare prices $2.25B notes offering; upsized senior notes to 6.00% due 2033","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Offering: $1.5B 5.500% first lien notes due 2032 and $0.75B 6.000% senior notes due 2033 (upsized from $0.5B).","Proceeds to redeem all $1.5B of 6.250% second lien notes due 2027 and partially redeem $0.75B of 6.125% senior notes due 2028.","Redemption date Nov 19, 2025; closing of new notes expected Nov 18, 2025.","Notes offered privately to QIBs and non-U.S. persons under Rule 144A/Reg S."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":130199,"accession_number":"0000070318-25-000043","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2025-10-28T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Tenet Q3 adjusted EPS $3.70 beats $2.93 YoY; raises FY2025 EBITDA outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income $342M ($3.86 diluted); adjusted EPS $3.70, up 26.3% YoY from $2.93.","Consolidated Adjusted EBITDA $1.099B, +12.4% YoY; margin 20.8%.","Same-facility ambulatory revenue +8.3%; hospital segment EBITDA $607M (+12.6%).","FY2025 Adjusted EBITDA guidance raised to $4.47B-$4.57B (midpoint +$50M).","Repurchased 0.6M shares for $93M in Q3; net debt/EBITDA 2.30x."],"consensus_eps_estimate":null,"consensus_eps_actual":11.28,"consensus_revenue_estimate":null,"consensus_revenue_actual":15783000000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":146765,"accession_number":"0000070318-25-000031","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2025-07-22T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Tenet Q2 adjusted EPS $4.02 (+74% YoY); raises FY 2025 EBITDA outlook to $4.40-$4.54B","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 2025 net income $288M, $3.14 diluted EPS; adjusted diluted EPS $4.02 vs $2.31 in Q2 2024.","Consolidated Adj. EBITDA $1.121B (+18.6% YoY); margin 21.3%. Ambulatory Care Adj. EBITDA $498M (+11.4%).","Board authorized $1.5B increase to share repurchase program, leaving $1.781B remaining as of July 22.","FY 2025 Adj. EBITDA outlook raised to $4.40-$4.54B (midpoint +$395M vs prior). Free cash flow guide $2.025-$2.275B.","H1 2025 free cash flow $1.385B vs $948M in H1 2024; net debt/Adj. EBITDA 2.45x."],"consensus_eps_estimate":null,"consensus_eps_actual":7.43,"consensus_revenue_estimate":null,"consensus_revenue_actual":10494000000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":165184,"accession_number":"0000070318-25-000023","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2025-06-05T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Tenet Healthcare promotes Lisa Y. Foo to Chief Operating Officer (newly created role)","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Lisa Y. Foo named COO effective May 30, 2025; position is newly created.","Biographical details incorporated by reference from proxy statement filed April 11, 2025.","Foo's promotion signals potential structural realignment of operations."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":165183,"accession_number":"0000070318-25-000020","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2025-05-27T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Tenet Healthcare shareholders elect all 13 directors, approve say-on-pay","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All 13 director nominees elected with strong support; Saumya Sutaria received 75.1M for, 3.2M against.","Advisory vote on executive compensation passed with 72.9M for (93% of votes cast excluding broker non-votes).","Ratification of Deloitte & Touche as auditor for FY2025 approved with 85.3M for.","Shareholder proposal on maternal health outcomes failed with only 3.8M for, 73.1M against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":165182,"accession_number":"0000070318-25-000013","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2025-04-29T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Tenet Q1 adjusted EPS $4.36, +35% YoY; Adj EBITDA $1.163B, +13.6%; guides FY adj EBITDA $3.975-4.175B","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income available to common shareholders $406M ($4.27 diluted) vs $2.151B in Q1 2024 (prior year included $2.5B divestiture gain).","Adjusted diluted EPS $4.36 vs $3.22, +35.4%; consolidated net operating revenues $5.223B (down 2.7% due to hospital divestitures).","Ambulatory Care segment Adj EBITDA $456M (+15.7%), revenue per case up 9.1%; Hospital segment Adj EBITDA $707M (+12.2%) on 4.4% same-hospital admissions growth.","Free cash flow $642M, up from $346M; repurchased 2.63M shares for $348M during Q1.","FY 2025 outlook: Adj EBITDA $3.975-$4.175B; Adj diluted EPS $11.99-$13.12; free cash flow $1.8-$2.05B."],"consensus_eps_estimate":null,"consensus_eps_actual":4.27,"consensus_revenue_estimate":null,"consensus_revenue_actual":5223000000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":182872,"accession_number":"0000070318-25-000005","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2025-02-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Tenet Q4 EPS $3.32 (adj. $3.44); FY2025 adj. EBITDA guidance $3.975-4.175B","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net income $318M ($3.32 diluted); adjusted EPS $3.44 vs $2.68 year ago.","Q4 net operating revenue $5.072B (down 5.7% YoY from $5.379B on hospital divestitures).","Q4 consolidated adjusted EBITDA $1.048B (20.7% margin); Ambulatory adj. EBITDA up 14.2% to $530M.","FY2025 outlook: adj. EBITDA $3.975-4.175B, adj. EPS $11.74-12.84, free cash flow $1.8-2.05B.","Net debt-to-adjusted EBITDA improved to 2.54x at Dec 31, 2024; repurchased 5.6M shares for $672M in 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":32.7,"consensus_revenue_estimate":null,"consensus_revenue_actual":20665000000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":182871,"accession_number":"0000070318-25-000003","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2025-01-24T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Tenet Healthcare enters amended employment agreement with CEO Saumya Sutaria through Dec 2028; $18M retention RSUs","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Base salary $1.5M; target annual bonus at least 200% of base ($3M).","Retention RSUs $18M: 40% time-vesting over 4 installments; 60% performance-based over 4 years (2025-2028).","Agreement term through Dec 31, 2028, with auto-renewal; severance includes 2.5x base+target (non-CIC) or 3x (CIC) plus health benefits.","Non-compete with 4 specified competitors for 1 year post-employment; non-solicit for 2 years; perpetual confidentiality."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":199455,"accession_number":"0000070318-24-000049","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2024-10-29T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Tenet Q3 adj. EPS $2.93 beats; raises FY24 EBITDA outlook to $3.9B-$4.0B","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 net income $472M ($4.89 diluted) includes $2.16 gain from hospital divestiture; adj. EPS $2.93.","Consolidated Adj. EBITDA $978M (+14.5% YoY); Ambulatory segment Adj. EBITDA $439M (+18.6%).","FY2024 Adj. EBITDA guidance raised by $50M to $3.9B-$4.0B; net operating rev. guidance $20.6B-$20.8B.","Free cash flow for 9 months $1.777B; share repurchases $672M YTD; net debt/EBITDA improved to 2.22x.","Completed sale of 70% stake in Brookwood Baptist Health (5 AL hospitals) to Orlando Health in Q3."],"consensus_eps_estimate":null,"consensus_eps_actual":29.27,"consensus_revenue_estimate":null,"consensus_revenue_actual":15593000000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":215489,"accession_number":"0000070318-24-000044","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2024-08-05T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"Tenet to sell 70% stake in five Alabama hospitals to Orlando Health for $910M cash","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Sale price $910M cash; after-tax proceeds ~$790M; pre-tax book gain ~$375M.","Five hospitals: Brookwood, Princeton, Walker, Shelby, Citizens Baptist Medical Centers.","12-month pre-tax income ~$12M; Adj. EBITDA less NCI ~$60M on Tenet's 70% interest.","Conifer Health Solutions gets new 10-year revenue cycle management contract for the facilities.","Expected fall 2024 close; FY24 Adjusted EBITDA outlook reaffirmed per July 24 guidance."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":215488,"accession_number":"0000070318-24-000037","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2024-07-24T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Tenet Q2 Net Income $259M, Adj EPS $2.31; Raises FY 2024 EBITDA, FCF Outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 net income $259M ($2.64 diluted EPS), up from $123M ($1.15) YoY; adjusted EPS $2.31.","Consolidated Adjusted EBITDA $945M (+12.1% YoY); Ambulatory Care EBITDA $447M (+20.8%).","New $1.5B share repurchase authorization; completed prior $1B program with 4.8M shares bought in H1 2024.","FY 2024 Adjusted EBITDA guidance raised to $3.825-3.975B (+$300M); FCF outlook raised to $1.1-1.35B (+$150M).","Same-hospital admissions up 5.2% vs Q2 2023; same-facility ambulatory surgical cases +0.2% with net rev/case +6.8%."],"consensus_eps_estimate":null,"consensus_eps_actual":24.22,"consensus_revenue_estimate":null,"consensus_revenue_actual":10471000000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":234826,"accession_number":"0000070318-24-000034","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2024-05-23T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Tenet Healthcare shareholders elect all 13 director nominees, approve executive compensation, ratify auditor","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All 13 director nominees elected; votes for ranged from 78.4M to 81.2M.","Say-on-pay advisory approved: 78.3M for (96.2%), 2.9M against.","Ratification of Deloitte as auditor: 88.0M for (99.4%), 0.5M against.","Shareholder proposal on abortion risk report defeated: 75.9M against, 4.1M for.","Shareholder proposal on ESG metrics in compensation defeated: 76.6M against, 4.3M for."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":234825,"accession_number":"0000070318-24-000030","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2024-04-30T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Tenet Q1 adj EPS $3.22 beats; revenue $5.37B; raises FY2024 EBITDA outlook to $3.5-3.7B","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 net income $2.15B ($21.38 diluted) includes $1.86B after-tax gain from hospital sales; adjusted diluted EPS $3.22.","Consolidated revenue $5.37B (+6.9% YoY); Adjusted EBITDA $1.02B (+23.1% YoY).","Ambulatory segment Adjusted EBITDA $394M (+15.9% YoY); Hospital segment Adjusted EBITDA $630M (+28.0% YoY).","FY2024 Adjusted EBITDA outlook raised by $215M to $3.50-$3.70B; Q2 guidance: $835-$885M.","Repurchased 2.8M shares for $278M; retired $2.1B of 4.875% notes due 2026, reducing annual cash interest by $102M."],"consensus_eps_estimate":null,"consensus_eps_actual":21.38,"consensus_revenue_estimate":null,"consensus_revenue_actual":5368000000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":234824,"accession_number":"0000070318-24-000022","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2024-04-01T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Tenet Healthcare completes sale of six California hospitals to UCI Health and Adventist Health","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Four Orange County and LA County hospitals sold to UCI Health: Fountain Valley Regional, Lakewood Regional Medical Center, Los Alamitos Medical Center, Placentia-Linda Hospital.","Two San Luis Obispo hospitals sold to Adventist Health: Sierra Vista Regional Medical Center and Twin Cities Community Hospital.","Sale terms consistent with previously disclosed amounts; no new financial details provided.","Transaction closed on April 1, 2024; all related operations included."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":252678,"accession_number":"0000070318-24-000020","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2024-02-29T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"Tenet sells two California hospitals for $550M cash; Conifer to partner with Adventist Health","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Sale of Sierra Vista Regional Medical Center and Twin Cities Community Hospital for $550M (after-tax ~$450M).","Divested facilities generated 2023 revenue of $337M, pre-tax income $25M, Adjusted EBITDA $38M.","Tenet estimates a pre-tax book gain of ~$275M on the transaction.","Conifer Health Solutions will provide revenue cycle services for Adventist Health, covering over $3.5B in net revenue.","Transaction expected to close spring 2024, subject to regulatory approvals including HSR."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":252677,"accession_number":"0000070318-24-000017","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2024-02-16T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Tenet calls for full redemption of $2.1B 4.875% Senior Secured Notes due 2026","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["All $2.1 billion aggregate principal of 4.875% Senior Secured First Lien Notes due 2026 called for redemption.","Redemption date is March 5, 2024, at 100% of principal plus accrued interest up to but not including that date.","Redemption will be funded with cash on hand, per the press release.","The Notes were issued under the Indenture dated November 6, 2001, as supplemented."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":252676,"accession_number":"0000070318-24-000011","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2024-02-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Tenet Q4 net income $244M, adj EBITDA $1.012B (+12.8% YoY); 2024 outlook $3.285-3.485B adj EBITDA","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 GAAP diluted EPS $2.30 vs $0.92 YoY; adjusted diluted EPS $2.68 vs $1.96.","Ambulatory Care adj EBITDA $464M (+14.0% YoY) on 3.9% same-facility surgical case growth.","Completed sale of three SC hospitals to Novant Health for ~$2.4B on Feb 1; signed deal to sell four CA hospitals to UCI Health for ~$975M.","FY 2024 outlook: adj EBITDA $3.285B-$3.485B; net rev $19.9B-$20.3B; adj EPS $5.76-$6.90.","Q4 hospital segment adj EBITDA excl. grant income $546M vs $450M YoY; same-hospital non-COVID admissions +2.6%."],"consensus_eps_estimate":null,"consensus_eps_actual":5.71,"consensus_revenue_estimate":null,"consensus_revenue_actual":20548000000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":252675,"accession_number":"0000070318-24-000008","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2024-02-01T23:59:59+00:00","items":["2.01","9.01","7.01"],"status":"ready","headline":"Tenet completes sale of three SC hospitals to Novant Health for $2.4B cash, expects ~$1.7B pretax gain","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Completed sale of three South Carolina hospitals plus affiliated physician practices and other operations to affiliates of Novant Health for $2.4B cash (subject to customary adjustments).","Transaction expected to generate a pretax gain of approximately $1.7B; income tax expense favorably impacted by ~$150M in 2024.","Pro forma balance sheet shows cash increase to $3.45B and net gain of $1.1B after tax; retained earnings deficit becomes positive.","Pro forma revenue for FY2022 reduced by $534M (to $18.64B) and for 9M2023 by $412M (to $14.76B) reflecting removal of divested operations.","Sale proceeds net of $5M transaction costs; net book value of divested assets $284M, goodwill allocated $425M."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":252674,"accession_number":"0000070318-24-000006","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2024-02-01T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"Tenet sells 3 SC hospitals for $2.4B, agrees to sell 4 CA hospitals for $975M; FY23 EBITDA above guidance high end","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Completed sale of three SC hospitals (Coastal Carolina, Hilton Head, East Cooper) to Novant for $2.4B cash.","Definitive agreement to sell four CA hospitals (Fountain Valley, Lakewood, Los Alamitos, Placentia Linda) to UCI Health for $975M.","Preliminary FY23 Adjusted EBITDA expected above high end of guidance, with $52M Medicaid adjustments and strong USPI surgical growth.","Four CA hospitals generated ~$1B revenue, $29M pre-tax income, $71M Adjusted EBITDA in 2023; estimated pre-tax gain ~$500M.","Combined tax benefit from both transactions ~$190M in 2024; transactions expected to close spring 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":270159,"accession_number":"0000070318-23-000060","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2023-12-13T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Tenet Healthcare appoints Vineeta Agarwala to Board of Directors, effective Dec 11, 2023","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Board size increased from 12 to 13 upon Dr. Agarwala's appointment.","She will serve on the Quality, Compliance & Ethics Committee and Human Resources Committee.","Dr. Agarwala is eligible for standard non-employee director compensation per 2023 proxy.","No arrangements or material transactions exist in connection with her appointment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":270158,"accession_number":"0000070318-23-000058","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2023-11-17T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"Tenet sells three SC hospitals to Novant for $2.4B cash; expects ~$1.6B pre-tax gain","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Sale includes Coastal Carolina, East Cooper Medical, Hilton Head hospitals and related operations.","LTM revenue of $552M, pre-tax income $126M, Adjusted EBITDA $150M (12 mo. ended Sep 30, 2023).","After-tax proceeds ~$1.75B; proceeds primarily for debt retirement.","Conifer Health enters new 15-year revenue cycle management contract for the sold hospitals.","Transaction expected to close Q1 2024, subject to HSR and regulatory approvals."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":270157,"accession_number":"0000070318-23-000054","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2023-10-30T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Tenet Q3 adj EPS $1.44; raises FY 2023 EBITDA outlook to $3.365-3.465B","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income $101M ($0.94 GAAP); adjusted diluted EPS $1.44 vs $1.42 YoY.","Revenue $5,066M (+5.5% YoY); consolidated Adj. EBITDA $854M (+$13M YoY).","Ambulatory Care Adj. EBITDA $370M (+16.0% YoY); same-facility surgical cases +4.1%.","FY 2023 Adj. EBITDA outlook raised to $3.365-3.465B; free cash flow $327M in Q3.","Repurchased 1.5M shares for $90M in nine months; net debt/EBITDA 4.08x."],"consensus_eps_estimate":null,"consensus_eps_actual":3.41,"consensus_revenue_estimate":null,"consensus_revenue_actual":15169000000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":287136,"accession_number":"0001193125-23-231607","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2023-09-08T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Tenet extends $200M LC facility to March 2027, switches to SOFR","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Extended letter of credit facility maturity from Sept 2024 to March 2027.","Replaced LIBOR with Term SOFR as the reference interest rate.","Facility size stays at $200M; Tenet also has a $1.5B revolver maturing March 2027.","Amendment executed Sept 7, 2023 with Barclays as administrative agent."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":287133,"accession_number":"0000070318-23-000047","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K/A","filed_at":"2023-08-11T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Tenet CFO Cancelmi to stay part-time through Apr 2025 at $750/week under transition agreement","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CFO Daniel Cancelmi signed transition agreement Aug 9, 2023; full-time employment ends Dec 31, 2023.","Part-time transition role from Jan 1, 2024 to Apr 15, 2025 at weekly salary of $750.","Cancelmi continues medical/dental/vision benefits until age 65; equity awards vest through Apr 15, 2025.","Receives service credit under SERP; restrictive covenants extended through Apr 2028, includes release of claims."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":287135,"accession_number":"0000070318-23-000045","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2023-08-10T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Tenet Healthcare appoints former U.S. Senator Roy Blunt to Board of Directors","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Senator Roy Blunt appointed to Tenet's Board effective August 9, 2023; Board expands from 11 to 12 members.","Blunt will serve on Audit, Nominating and Corporate Governance, and ESG Committees.","Blunt's term expires at the 2024 Annual Meeting; he receives standard non-employee director compensation.","No material arrangements or transactions exist between Blunt and Tenet."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":287134,"accession_number":"0000070318-23-000040","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2023-07-31T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Tenet Q2 net income $123M ($1.15/diluted); raises FY23 EBITDA view to $3.31-3.46B","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income from continuing ops $123M ($1.15/diluted); adjusted EPS $1.44; revenue $5.08B, up from $4.64B YoY.","Ambulatory Care Adj. EBITDA ex-grant $369M (+16.4% YoY); same-facility surgical cases +6.6%.","Hospital segment Adj. EBITDA ex-grant $381M; same-hospital admissions +3.0%, non-COVID admissions +5%.","FY2023 Adj. EBITDA guidance raised to $3.31-3.46B; FCF outlook $1.1-1.35B.","Completed $1.35B 6.75% notes private placement; redeemed $1.345B 4.625% notes due 2024; no debt maturities until 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":2.47,"consensus_revenue_estimate":null,"consensus_revenue_actual":10103000000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":307224,"accession_number":"0000070318-23-000033","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2023-06-23T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Tenet names Sun Park as CFO effective Jan 2024; replaces retiring Dan Cancelmi","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Sun Park appointed EVP & CFO effective Jan 1, 2024; will serve as EVP from July 11, 2023.","Park previously EVP & Group CFO at AmerisourceBergen, overseeing $240B+ annual revenues.","Compensation: $700K base, target 100% bonus, sign-on $1M, RSU grant $1.67M, plus 2024 equity.","Dan Cancelmi retires Dec 31, 2023 as previously announced; transition is planned.","Park reports to CEO Saum Sutaria; will lead all finance functions including IR."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":307223,"accession_number":"0000070318-23-000028","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2023-05-30T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Tenet Healthcare appoints Stephen H. Rusckowski to Board of Directors","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Stephen H. Rusckowski appointed to Tenet's Board, effective May 25, 2023.","Board expands from 10 to 11 directors; Rusckowski on Human Resources and Quality/Compliance/Ethics Committees.","He will receive standard non-employee director compensation; no arrangements or related-party transactions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":307222,"accession_number":"0000070318-23-000026","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2023-05-25T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Tenet Healthcare annual meeting: all director nominees elected, say-on-pay passes","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All 10 director nominees elected with majority FOR votes; highest was Saumya Sutaria with 85.7M FOR.","Advisory vote on executive compensation approved with 81.5M FOR (93.9% of votes cast).","Shareholders voted for annual advisory votes on exec compensation (84.5M for one year).","Ratification of Deloitte as auditor approved with 92.6M FOR.","Shareholder proposal on abortion access failed with 77.4M AGAINST."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":307221,"accession_number":"0001193125-23-146125","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2023-05-16T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Tenet Healthcare issues $1.35B of 6.750% senior secured notes due 2031 to refinance near-term debt","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $1,350,000,000 aggregate principal of 6.750% senior secured first lien notes due 2031.","Proceeds will redeem $756M of 4.625% notes due July 2024 and $589M of 4.625% notes due September 2024.","Notes are callable at make-whole prior to May 15, 2026, then at specified redemption prices.","Indenture has no restrictions on incurring additional debt, paying dividends, or making restricted payments.","Issued under existing base indenture with fortieth supplemental indenture dated May 16, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":307220,"accession_number":"0000070318-23-000024","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2023-05-02T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"Tenet prices $1.35B 6.75% secured notes due 2031 to refinance 2024 debt","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $1.35B of 6.750% senior secured first lien notes maturing May 15, 2031; closing expected May 16.","Net proceeds, with cash on hand, to redeem $756M of 4.625% notes due July 2024 and $589M due Sept 2024.","Redemption dates: Sept 2024 notes on May 17; July 2024 notes on June 1.","Notes are secured and guaranteed by certain subsidiaries; offered privately to QIBs and non-U.S. persons.","Interest rate increases from 4.625% to 6.750% but extends maturity from 2024 to 2031."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":307219,"accession_number":"0000070318-23-000015","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2023-04-25T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Tenet Q1 adj EPS $1.42 rev $5.02B; raises FY23 EBITDA outlook to $3.21-3.41B","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 net income from continuing ops $143M ($1.32 dil EPS); adj diluted EPS $1.42 vs $1.90 YoY.","Consolidated Adj EBITDA $832M incl $3M grants; ex-grants $829M vs $882M prior.","Ambulatory segment revs +22.6% to $905M; Adj EBITDA ex-grants +21.4% to $340M.","Hospital segment Adj EBITDA ex-grants $402M vs $510M; included $27M cyber insurance proceeds.","FY2023 Adj EBITDA outlook raised to $3.21-3.41B; Q2 outlook Adj EBITDA $765-815M."],"consensus_eps_estimate":null,"consensus_eps_actual":1.32,"consensus_revenue_estimate":null,"consensus_revenue_actual":5021000000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":326267,"accession_number":"0000070318-23-000006","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2023-02-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Tenet Q4 net income $102M ($0.92 diluted EPS), FY2023 Adj. EBITDA guidance $3.16B-$3.36B","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2022 net income from continuing ops $102M ($0.92 diluted EPS) vs $250M ($2.30) a year ago; adjusted diluted EPS $1.96 vs $2.70.","Consolidated Q4 Adj. EBITDA $897M (incl $40M grant income) vs $1.017B; Ambulatory Adj. EBITDA ex-grant grew 18.7% to $407M.","FY2023 outlook: Adj. EBITDA $3.16B-$3.36B, adjusted diluted EPS $4.68-$5.85; net operating revenues $19.7B-$20.1B.","Repurchased 5.9M shares for $250M in Q4; entered deal to sell San Ramon Regional Medical Center for $142.5M (close expected 2023)."],"consensus_eps_estimate":null,"consensus_eps_actual":3.79,"consensus_revenue_estimate":null,"consensus_revenue_actual":19174000000.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":326266,"accession_number":"0000070318-23-000004","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2023-01-19T23:59:59+00:00","items":["2.02","5.02","7.01","9.01"],"status":"ready","headline":"Tenet expects FY22 Adj. EBITDA slightly above $3.425B midpoint; CFO to retire","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["Prelim FY22 Adj. EBITDA (ex-pandemic grants) slightly above $3.425B guidance midpoint.","All three business segments met or slightly exceeded their adjusted EBITDA midpoint.","CFO Daniel Cancelmi to retire Dec 31, 2023; national search for successor underway.","USPI CEO Brett Brodnax retiring end of 2023; Andy Johnston expected to take over.","Conifer CEO Roger Davis retiring Q1 2023; multiple internal promotions announced."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":343982,"accession_number":"0000070318-22-000047","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2022-10-20T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Tenet Q3 net income $131M, adj EPS $1.44; announces $1B buyback; FY22 EBITDA outlook narrowed","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 net income from continuing ops $131M ($1.16 diluted EPS); adjusted diluted EPS $1.44.","Consolidated Adj. EBITDA $841M vs $855M in Q3 2021; USPI (ambulatory) EBITDA up 16.4% to $319M.","Board authorized $1B share repurchase program expiring Dec 31, 2024.","FY2022 Adj. EBITDA outlook revised to $3.375-$3.475B, ~1% change at midpoint.","Repaid $880M Medicare advances; free cash flow $190M in 9 months (excl. advances $1.07B)."],"consensus_eps_estimate":null,"consensus_eps_actual":2.82,"consensus_revenue_estimate":null,"consensus_revenue_actual":14184000000.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":343981,"accession_number":"0001193125-22-256098","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2022-10-03T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Executive Chairman Rittenmeyer resigns due to health; J. Robert Kerrey appointed Chairman","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Ronald A. Rittenmeyer resigned as Executive Chairman and Board member effective Oct 1, 2022 due to personal health reasons.","Board appointed J. Robert Kerrey, former Lead Director, as Chairman; Board reduced to ten directors.","Letter agreement treats resignation as disability termination under Rittenmeyer's employment agreement.","Senator Kerrey has served on Board since 2001, currently Managing Director at Allen & Company."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":360485,"accession_number":"0000070318-22-000036","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2022-07-21T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Tenet Q2 net income falls 68% to $38M; adjusted EBITDA up 1% to $843M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income from continuing ops $38M ($0.35 EPS) vs $120M ($1.11) in Q2'21.","Adjusted EBITDA $843M (+1% YoY); Adjusted diluted EPS $1.50 vs $1.59.","Cybersecurity incident drove same-hospital adjusted admissions down 5.3% YoY.","Acquired remaining 5% of USPI for $406M; now owns 100% of USPI voting stock.","Reaffirmed FY 2022 Adjusted EBITDA outlook of $3.375B-$3.575B."],"consensus_eps_estimate":null,"consensus_eps_actual":1.64,"consensus_revenue_estimate":null,"consensus_revenue_actual":9383000000.0,"consensus_period":"2022-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":379531,"accession_number":"0001193125-22-174770","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2022-06-15T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Tenet issues $2B of 6.125% senior secured notes due 2030 to redeem 2023 notes","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$2B aggregate principal of 6.125% senior secured first lien notes due 2030 issued.","Net proceeds to redeem all outstanding 6.750% senior notes due 2023.","Covenants restrict liens, subsidiary guarantees, asset sales, mergers; no restrictions on additional debt, dividends, or investments.","Notes callable at make-whole premium prior to June 2025, then at stated redemption prices.","Exchange and registration rights agreement; special interest up to 1.0% additional if registration defaults occur."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":379530,"accession_number":"0001193125-22-165333","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2022-06-01T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"Tenet Healthcare Prices $2.0 Billion Senior Secured Notes Offering to Redeem 2023 Notes","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Tenet Healthcare upsized its private offering of senior secured first lien notes to $2.0 billion, priced at 6.125% due 2030.","The notes will be used to redeem all $1.748 billion of its 6.750% senior notes due 2023, with redemption expected on July 1, 2022.","The offering was initially announced at $1.8 billion and increased to $2.0 billion; closing expected June 15, 2022.","The notes are secured on a first lien basis and guaranteed by certain subsidiaries."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":379529,"accession_number":"0000070318-22-000033","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2022-05-09T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Tenet shareholders elect 11 directors, approve say-on-pay and stock plan amendment","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All 11 director nominees elected with majority support; Rittenmeyer received 86.7M for, 1.3M against.","Advisory vote on executive compensation approved: 85.1M for, 2.8M against.","First Amendment to 2019 Stock Incentive Plan approved: 85.6M for, 2.3M against.","Ratification of Deloitte & Touche as auditor for 2022 approved: 93.9M for, 0.9M against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":379528,"accession_number":"0000070318-22-000023","cik":70318,"company_name":"TENET HEALTHCARE CORP","ticker":"THC","form_type":"8-K","filed_at":"2022-04-20T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Tenet Q1 adj. EBITDA $882M (ex. grants) beats outlook; net income $139M; retired $824M debt","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income from continuing ops $139M vs $97M YoY; adj. diluted EPS $1.93 vs $1.30.","Consolidated adj. EBITDA $888M ($882M ex. grants) exceeded Q1 outlook; Q1'21 $777M ($740M ex. grants).","Retired $824M of debt YTD including $700M 7.5% senior secured notes; expects $61M annual interest savings.","Same-facility ambulatory surgical cases +8.0% YoY; same-hospital adjusted admissions -1.4% due to Omicron.","Free cash flow $73M ($267M ex. Medicare advance repayments); maintained 2022 adj. EBITDA outlook."],"consensus_eps_estimate":null,"consensus_eps_actual":1.28,"consensus_revenue_estimate":null,"consensus_revenue_actual":4745000000.0,"consensus_period":"2022-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":15595965840.026306,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2022-04-20T23:59:59+00:00|379528"}